Fibroadipogenic progenitor cells as drivers of angiogenesis during muscle regeneration

纤维脂肪祖细胞作为肌肉再生过程中血管生成的驱动因素

基本信息

  • 批准号:
    10741438
  • 负责人:
  • 金额:
    $ 42.09万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-19 至 2025-08-31
  • 项目状态:
    未结题

项目摘要

ABSTRACT Skeletal muscle comprises nearly half of body mass and is subject to traumatic injuries, particularly of the extremities. Damaged muscle mass and function must be restored promptly to minimize physical distortion and prevent long-term disabilities. Furthermore, poor outcomes impose significant emotional and financial burdens on affected individuals and their families. An aspirational goal of the NICHD is to advance the ability to regenerate human limbs by using emerging technologies to activate the body’s own growth pathways and processes. Under most circumstances damaged muscle is efficiently regenerated through a coordinated multicellular response involving muscle stem cells (satellite cells, SCs), endothelial cells (ECs), and fibroblasts or fibroadipogenic precursor cells (FAPs) as well as other resident and infiltrating cell types. However, after the loss of tissue over a critical threshold (volumetric muscle loss, VML), tissue regeneration does not occur and neither mass nor function are regained. The molecular and cellular mechanisms underlying the distinction between subthreshold, regenerating wounds vs. nonregenerating VML are not yet sufficiently understood, posing a critical roadblock to development of translational interventions. A novel punch biopsy model of injury and regeneration developed in the PI’s laboratory using the mouse gluteus maximus muscle highlights the sequential activity of FAPs, ECs, and SCs in successful muscle regeneration. A key observation is that if local FAPs are removed, both angiogenesis and myogenesis fail to occur, making the subthreshold injury instead resemble VML. Whether FAPs effect this relationship by direct actions on ECs, myogenic cells, or both is unknown. Therefore, this research project proposes to: 1) confirm the requirement for FAPs in permitting healing of a subcritical VML injury; 2) test the ability of a candidate molecule, periostin, to rescue microvascular and myofiber regeneration in wounds lacking FAPs; 3) determine whether periostin signals directly to ECs, myogenic cells, or both; and 4) perform an unbiased proteomic screen for additional signaling molecules either secreted directly by FAPs or induced in ECs or myogenic cells by FAPs that may promote the regeneration of intact muscle. These experiments will leverage the team's collective expertise in microvascular imaging, muscle regeneration, FAPs biology, and biomaterials to identify, characterize, and functionally test key cellular and molecular factors differentiating between muscle injuries which heal successfully and those which cannot. If successful, this research project will identify molecules and methods which have the potential to be translated into therapies designed to improve clinical outcomes for disabled individuals, thereby addressing a key unmet need in both basic and applied muscle biology.
摘要 骨骼肌占身体质量的近一半,并且容易受到创伤性损伤,尤其是骨骼肌 四肢受损的肌肉质量和功能必须迅速恢复,以尽量减少身体变形, 预防长期残疾。此外,不良的结果会带来重大的情感和经济负担 受影响的个人及其家庭。NICHD的理想目标是提高再生能力 通过使用新兴技术来激活人体自身的生长途径和过程,下 在大多数情况下,受损的肌肉通过协调的多细胞反应有效地再生, 涉及肌肉干细胞(卫星细胞,SC)、内皮细胞(EC)和成纤维细胞或成纤维脂肪细胞, 前体细胞(FAP)以及其他驻留和浸润细胞类型。然而,在组织损失超过 临界阈值(肌肉体积损失,VML),组织再生不会发生, 功能恢复。阈下、阈下和阈下之间区别的分子和细胞机制, 再生性伤口与非再生性VML尚未得到充分理解, 翻译干预的发展。一种新的损伤和再生的穿刺活检模型, PI使用小鼠臀大肌的实验室强调了FAP,EC和 SC在成功的肌肉再生。一个关键的观察结果是,如果去除局部FAP, 并且肌生成不能发生,使得阈下损伤反而类似于VML。FAP是否会影响这一点 直接作用于EC、肌原细胞或两者的关系尚不清楚。因此,本研究项目 建议:1)确认FAP在允许亚临界VML损伤愈合方面的要求; 2)测试 一种候选分子,骨膜蛋白,拯救缺乏微血管和肌纤维再生的伤口的能力, FAP; 3)确定骨膜蛋白是否直接向EC、肌源性细胞或两者发出信号;以及4)进行无偏定量分析。 蛋白质组学筛选由FAP直接分泌或在EC中诱导的额外信号分子, FAP可以促进完整肌肉的再生。这些实验将利用 该团队在微血管成像、肌肉再生、FAPs生物学和生物材料方面的集体专业知识 识别,表征和功能测试区分肌肉和肌肉之间的关键细胞和分子因子, 成功治愈的伤和不能治愈的伤如果成功,该研究项目将确定 这些分子和方法有可能被转化为旨在改善临床症状的疗法, 结果为残疾人,从而解决了一个关键的未满足的需求,在基础和应用肌肉 生物学

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STEVEN S SEGAL其他文献

STEVEN S SEGAL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STEVEN S SEGAL', 18)}}的其他基金

Frontiers in Microcirculation: Control Processes and Clinical Applications
微循环前沿:控制过程和临床应用
  • 批准号:
    7749829
  • 财政年份:
    2009
  • 资助金额:
    $ 42.09万
  • 项目类别:
Microcirculation in Aging Skeletal Muscle
衰老骨骼肌的微循环
  • 批准号:
    7664509
  • 财政年份:
    2007
  • 资助金额:
    $ 42.09万
  • 项目类别:
Microcirculation in Aging Skeletal Muscle
衰老骨骼肌的微循环
  • 批准号:
    7262728
  • 财政年份:
    2007
  • 资助金额:
    $ 42.09万
  • 项目类别:
Microcirculation in Aging Skeletal Muscle
衰老骨骼肌的微循环
  • 批准号:
    7911746
  • 财政年份:
    2007
  • 资助金额:
    $ 42.09万
  • 项目类别:
Microcirculation in Aging Skeletal Muscle
衰老骨骼肌的微循环
  • 批准号:
    7467274
  • 财政年份:
    2007
  • 资助金额:
    $ 42.09万
  • 项目类别:
Microcirculation in Aging Skeletal Muscle
衰老骨骼肌的微循环
  • 批准号:
    8115064
  • 财政年份:
    2007
  • 资助金额:
    $ 42.09万
  • 项目类别:
Microcirculation in Aging Skeletal Muscle
衰老骨骼肌的微循环
  • 批准号:
    6431095
  • 财政年份:
    2002
  • 资助金额:
    $ 42.09万
  • 项目类别:
Microcirculation in Aging Skeletal Muscle
衰老骨骼肌的微循环
  • 批准号:
    6621219
  • 财政年份:
    2002
  • 资助金额:
    $ 42.09万
  • 项目类别:
UNIT CONTROL OF MUSCLE BLOOD FLOW
肌肉血流的单位控制
  • 批准号:
    6030765
  • 财政年份:
    1996
  • 资助金额:
    $ 42.09万
  • 项目类别:
Unit Control of Muscle Blood Flow
肌肉血流的单位控制
  • 批准号:
    7217021
  • 财政年份:
    1996
  • 资助金额:
    $ 42.09万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 42.09万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 42.09万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.09万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.09万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 42.09万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.09万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 42.09万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 42.09万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 42.09万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.09万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了